Cargando…
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
BACKGROUND: Since the beginning of the COVID-19 pandemic, several variants of concern (VOC) have emerged for which there is evidence of an increase in transmissibility, more severe disease, and/or reduced vaccine effectiveness. Effective COVID-19 vaccine strategies are required to achieve broad prot...
Autores principales: | Berry, Catherine, Pavot, Vincent, Anosova, Natalie G., Kishko, Michael, Li, Lu, Tibbitts, Tim, Raillard, Alice, Gautheron, Sylviane, Cummings, Sheila, Bangari, Dinesh S., Kar, Swagata, Atyeo, Caroline, Deng, Yixiang, Alter, Galit, Gutzeit, Cindy, Koutsoukos, Marguerite, Chicz, Roman M., Lecouturier, Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212738/ https://www.ncbi.nlm.nih.gov/pubmed/37237062 http://dx.doi.org/10.1038/s43856-023-00302-z |
Ejemplares similares
-
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates
por: Pavot, Vincent, et al.
Publicado: (2023) -
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
por: Pavot, Vincent, et al.
Publicado: (2022) -
Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023) -
An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques
por: Lecouturier, Valérie, et al.
Publicado: (2020) -
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
por: Dayan, Gustavo H., et al.
Publicado: (2023)